Commensal iron acquisition and nutritional immunity during Salmonella infection Original paper

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

August 22, 2025

  • Metals
    Metals

    OverviewHeavy metals play a significant and multifaceted role in the pathogenicity of microbial species. Their involvement can be viewed from two primary perspectives: the toxicity of heavy metals to microbes and the exploitation of heavy metals by microbial pathogens to establish infections and evade the host immune response. Understanding these aspects is critical for both […]

  • Iron (Fe)
    Iron (Fe)

    OverviewIron is a pivotal nutrient at the host–pathogen interface. Virtually all microbes (with rare exceptions like Borrelia) require iron for processes from DNA synthesis to respiration. [1] In human hosts, free iron is vanishingly scarce due to “nutritional immunity,” wherein iron is locked up in hemoproteins or tightly bound by transport proteins.[2] This metal tug-of-war […]

  • Microbes
    Microbes

    Microbes, short for microorganisms, are tiny living organisms that are ubiquitous in the environment, including on and inside the human body. They play a crucial role in human health and disease, functioning within complex ecosystems in various parts of the body, such as the skin, mouth, gut, and respiratory tract. The human microbiome, which is […]

  • Nutritional Immunity
    Nutritional Immunity

    Nutritional immunity restricts metal access to pathogens, leveraging sequestration, transport, and toxicity to control infections and immunity.

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Last Updated: 2025-08-22

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What was studied?

This study interrogates commensal iron acquisition and nutritional immunity during Salmonella infection, focusing on how the gut commensal Bacteroides thetaiotaomicron captures xenosiderophores to sustain fitness and inadvertently modulates host defenses against pathogens. The authors identify XusB, a secreted, surface-anchored lipoprotein that binds ferric enterobactin with high affinity and is enriched in outer membrane vesicles. They combine structural biology, biochemistry, bacterial genetics, and murine infection models to show that XusB-bound enterobactin resists sequestration by host lipocalin 2, can be re-acquired by Salmonella via FepA or IroN, and thereby alters the effective pool of iron chelators available under inflammatory iron restriction. The graphical abstract on page 2 schematically depicts enterobactin crossfeeding, OMV packaging of XusB, and reduced lipocalin 2 access, framing commensal iron acquisition as a third axis in nutritional immunity beyond host and pathogen.

Who was studied?

Experiments used B. thetaiotaomicron VPI-5482 and isogenic mutants lacking xusB or harboring an enterobactin-binding deficient XusB, along with Salmonella enterica serovar Typhimurium strains, including wild type, entB deficient, ΔfepA iroN double mutant, and ΔiroB lacking salmochelin synthesis. Escherichia coli BW25113 mutants from the Keio collection informed receptor requirements for XusB-bound siderophore uptake. In vivo work involved antibiotic-pretreated conventional C57BL/6 mice for competitive infection and colonization studies, and gnotobiotic Swiss Webster mice to measure XusB in luminal OMV fractions without confounding microbes. Figures 4 and 7 detail competitive indices for Salmonella in mice colonized with B. thetaiotaomicron variants or administered OMVs, while supplementary analyses confirm comparable inflammation readouts across conditions.

Most important findings

XusB is a surface-exposed, OMV-enriched lipoprotein required for B. thetaiotaomicron utilization of catecholate xenosiderophores. Structural work shows XusB forms a seven-bladed beta propeller with a positively charged central calyx that accommodates Fe-enterobactin; docking and mutagenesis identify key contact residues, and binding affinity is in the low-nanomolar range near 148 nM. In vitro, OMV-associated or recombinant XusB preloaded with Fe-enterobactin fuels growth of B. thetaiotaomicron under iron chelation, elevates cellular iron by ICP-MS, and supports growth of Salmonella entB mutants and E. coli via TonB-dependent enterobactin receptors FepA and IroN. In species with distinct XusB homologs, XusB-bound siderophores can be “selfish,” restricting access to closely related Bacteroides while remaining accessible to Enterobacteriaceae.

Crucially, XusB changes the competitive landscape in the presence of host lipocalin 2. When lipocalin 2 is added with an iron chelator, XusB increases the competitive index of wild-type Salmonella over the ΔfepA iroN mutant, indicating that XusB-bound enterobactin constitutes an exploitable pool despite host sequestration of free enterobactin. In mice, XusB confers a resilience advantage to B. thetaiotaomicron during Salmonella colitis and increases Salmonella fitness when animals are colonized with XusB-positive B. thetaiotaomicron or given XusB-bearing OMVs. Page 34 visualizes the XusB architecture and calyx electrostatics, pages 39 to 41 depict in vitro and in vivo competition assays that demonstrate altered siderophore accessibility and pathogen advantage.

Key implications

For microbiome signatures, B. thetaiotaomicron emerges as a context-dependent facilitator of pathogen iron access under inflammation, linking a commensal siderophore-binding system to Salmonella expansion. B. thetaiotaomicron with XusB-mediated xenosiderophore capture and Salmonella Typhimurium with enterobactin or salmochelin utilization. Clinically, strategies that modulate iron availability or deploy siderophore-binding therapeutics must account for commensal OMV cargo that can buffer host sequestration and inadvertently aid pathogens. Targeting XusB-like systems may represent a translational lever to restore nutritional immunity without broadly disrupting commensals.

Citation

Spiga L, Fansler RT, Perera YR, et al. Iron acquisition by a commensal bacterium modifies host nutritional immunity during Salmonella infection. Cell Host Microbe. 2023;31(10):1639-1654.e10. doi:10.1016/j.chom.2023.08.018.

Nutritional Immunity

Nutritional immunity restricts metal access to pathogens, leveraging sequestration, transport, and toxicity to control infections and immunity.

Escherichia coli (E. coli)

Escherichia coli (E. coli) is a versatile bacterium, from gut commensal to pathogen, linked to chronic conditions like endometriosis.

Nutritional Immunity

Nutritional immunity restricts metal access to pathogens, leveraging sequestration, transport, and toxicity to control infections and immunity.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.